REVLIMID 5 mg, Hartkapseln - 21 Kapsel(n) Swissmedic Key 57712001 Registration Holder Bristol-Myers Squibb SA Name REVLIMID 5 mg, Hartkapseln Date of registration 29.08.2007 Original/Generic Original Introduction of Sequence 29.08.2007 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 21 Kapsel(n) Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 2359.19 Limitation Yes Limitation text
Deductible 20 % Consumer price 2480.50 Feedback FB Daily cost GTIN 7680577120016 Medication Code Synthetika Pharmacode 3542285 Disponibility
Composition lenalidomidum 5 mg, lactosum 147 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.4 mg, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 5 mg
BAG: Active Agent Dose Lenalidomidum 5 mg
Inactive agents Dose additional_information (Nigrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Lactosum 147 mg Magnesii Stearas Pro Capsula Propylenglycol
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
